Kibion is a global leader in complete solutions for rapid reliable Urea Breath Tests for diagnosing the stomach ulcer bacterium Helicobacter pylori.
Kibion was founded in 2005, as a subsidiary of the Swedish pharmaceutical company Orexo AB, to create a clear focus for exploiting breakthrough discoveries in the diagnosis of Helicobacter pylori.
In 2011 Orexo acquired the German company Wagner Analysen Technik GmbH, a leading manufacturer of IRIS™ instruments for analyzing diagnostic breath tests. Integrating these two businesses transformed Kibion into a complete solutions provider of diagnostic breath tests and instrumentation, and a leading player in Helicobacter pylori testing.
The 30th of April 2015, Kibion was acquired by a team of Swedish investors and business devlopers. Through this investment Kibion will strengthen its operations and continue to grow.
The 30th of September 2016, Kibion was acquired by the French company Laboratory Mayoly Spindler. This acquisition will strengthen both companies’ globally and generate outstanding synergies.
Kibion, whose name originates from the old Nordic “Kibi” meaning smart and alert, offers innovative yet trustworthy solutions. The company currently supplies test systems and high-quality instruments to institutions, hospitals and laboratories in more than 50 countries around the world. In addition, it continuously evaluates new business opportunities within its field of operations.
At the heart of Sweden’s life-science center
Kibion is based in the Swedish university town of Uppsala, just north of Stockholm. The Uppsala/Stockholm region is a vigorous focal point for the country’s biotechnology and life-science industries. Uppsala boasts more than 50 biotech companies, two internationally recognized universities, a major university hospital and the Swedish Medical Products Agency.
Its German subsidiary, Kibion GmbH, is based in Bremen.